Literature DB >> 14700610

Testicular cancer: the challenge for cancer control.

Peter Boyle1.   

Abstract

The effect of the discovery of a curative treatment regimen for testicular cancer is apparent in countries with declining national mortality rates. The introduction of centralised treatment in Slovakia has been maintained, and the decline seen in the former country referred to as East Germany after rapid economic change is also clear and continuing. However, mortality remains higher in all countries of central and eastern Europe, compared with western European countries. Testicular cancer could almost be eliminated as a cause of death worldwide if the political will, adequate finance, and the necessary training and logistics to deliver appropriate treatment were implemented. The resources required to eliminate death from testicular cancer are resource-based, rather than dependent on the outcome of further research. The aim of all cancer research is to benefit the patient with cancer or those who are at risk of developing the disease. Testicular cancer control would be the finest illustration of this process and, simultaneously, would be a model for implementation as new, successful therapeutic modalities for other cancers are developed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14700610     DOI: 10.1016/s1470-2045(03)01325-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  8 in total

1.  Report on trends of incidence (1970-2002) of and mortality (1952-2002) from cancer in Germany.

Authors:  Nikolaus Becker; Hans-Peter Altenburg; Christa Stegmaier; Hartwig Ziegler
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-03       Impact factor: 4.553

2.  Incorporating non-biological factors into the TNM staging system for better prognostication and decision-making in testicular cancer.

Authors:  Yongqiang Huang; Haoyue Sheng; Junyu Zhang; Qi Liu; Dingwei Ye; Guohai Shi
Journal:  World J Urol       Date:  2018-12-15       Impact factor: 4.226

3.  Epidemiological pattern and time trends in testicular germ-cell tumors: a single institution 20-year experience.

Authors:  Jorge Molina Saera; Jorge Aparicio Urtasun; Roberto Díaz Beveridge; Laura Palomar Abad; Alejandra Giménez Ortiz; José Ponce Lorenzo; Joaquín Montalar Salcedo
Journal:  Clin Transl Oncol       Date:  2006-08       Impact factor: 3.405

4.  Epidemiology and treatment delay in testicular cancer patients: a retrospective study.

Authors:  Martina Ondrusova; Dalibor Ondrus
Journal:  Int Urol Nephrol       Date:  2007-07-18       Impact factor: 2.370

5.  Cancer epidemiology in Central, South and Eastern European countries.

Authors:  Eduard Vrdoljak; Marek Z Wojtukiewicz; Tadeusz Pienkowski; Gyorgy Bodoky; Peter Berzinec; Jindrich Finek; Vladimir Todorović; Nenad Borojević; Adina Croitoru
Journal:  Croat Med J       Date:  2011-08-15       Impact factor: 1.351

6.  Identification and validation of a five apoptosis-related genes signature for prediction of disease-free survival for testicular germ cell tumors.

Authors:  Tengyue Zeng; Liangyu Yao; Kai Zhao; Rong Cong; Xianghu Meng; Ninghong Song
Journal:  Transl Androl Urol       Date:  2021-03

7.  Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors.

Authors:  Oscar Arrieta; Rosa Mayela Michel Ortega; Julián Angeles-Sánchez; Cynthia Villarreal-Garza; Alejandro Avilés-Salas; José G Chanona-Vilchis; Elena Aréchaga-Ocampo; Arturo Luévano-González; Miguel Angel Jiménez; José Luis Aguilar
Journal:  J Exp Clin Cancer Res       Date:  2009-08-27

8.  HMGA2 expression distinguishes between different types of postpubertal testicular germ cell tumour.

Authors:  Lars Kloth; Andrea Gottlieb; Burkhard Helmke; Werner Wosniok; Thomas Löning; Käte Burchardt; Gazanfer Belge; Kathrin Günther; Jörn Bullerdiek
Journal:  J Pathol Clin Res       Date:  2015-09-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.